Medtronic CONNECT Trial Concludes Enrollment

Medtronic, Inc. (NYSE: MDT) announced that patient enrollment in its CONNECTSM trial has concluded. The trial is assessing how the use of the Medtronic CareLink® Network to remotely monitor patients with the Concerto® cardiac resynchronization therapy-defibrillator (CRT-D) and Virtuoso® implantable cardioverter-defibrillator (ICD) effectively enables better patient care and reduces unnecessary healthcare costs. Principal investigator is George Crossley, M.D.

More: continued here

Filed under: Cardiovascular on May 22nd, 2008